Circular RNA circ-SMAD7 promoted glioma cell proliferation and metastasis by upregulating PCNA

C-Y Zuo1, W Qian, C-J Huang

  • 1Department of Neurosurgery, The Ninth People's Hospital of Suzhou, Suzhou, China. zuochangyang@163.com.

Abstract

Insights

Circular RNA SMAD7 (circ-SMAD7) promotes glioma progression by upregulating proliferating cell nuclear antigen (PCNA). Targeting the circ-SMAD7/PCNA pathway may offer a new therapeutic strategy for glioma patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Circular RNAs (circRNAs) are a class of regulatory RNAs implicated in tumor progression.
  • Dysregulation of circRNAs is observed in various cancers, including glioma.
  • The specific role of circ-SMAD7 in glioma pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the function of circ-SMAD7 in glioma progression.
  • To explore the underlying molecular mechanism of circ-SMAD7 in glioma.
  • To evaluate circ-SMAD7 as a potential therapeutic target for glioma.

Main Methods:

  • Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) to detect circ-SMAD7 expression in glioma tissues.
  • Cellular assays including proliferation, cell cycle, migration, and invasion assays to assess circ-SMAD7 function.
  • Western blot and qRT-PCR to analyze the interaction between circ-SMAD7 and proliferating cell nuclear antigen (PCNA).

Main Results:

  • Circ-SMAD7 expression was significantly higher in glioma tissues compared to adjacent samples.
  • Downregulation of circ-SMAD7 inhibited glioma cell proliferation, migration, and invasion, and regulated the cell cycle.
  • Circ-SMAD7 positively correlated with PCNA expression, and its knockdown reduced PCNA mRNA and protein levels.

Conclusions:

  • Circ-SMAD7 promotes glioma proliferation and metastasis by upregulating PCNA.
  • The circ-SMAD7/PCNA axis represents a potential novel therapeutic strategy for glioma treatment.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: